Avanos Medical
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $170,400 | $171,700 | $166,100 | $173,300 |
Gross Profit | 92,900 | 95,600 | 94,800 | 97,400 |
EBITDA | 24,400 | 23,000 | 18,900 | 30,300 |
EBIT | 12,700 | 11,700 | 7,500 | 18,800 |
Net Income | 4,300 | 1,800 | -900 | 10,500 |
Net Change In Cash | 170,400 | 171,700 | 166,100 | 173,300 |
Free Cash Flow | 20,000 | 21,900 | -12,099 | 6,800 |
Cash | 89,000 | 92,200 | 75,800 | 87,700 |
Basic Shares | 46,600 | 46,300 | 46,200 | 46,600 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $673,300 | $820,000 | $744,600 | $714,800 |
Gross Profit | 379,700 | 450,000 | 364,300 | 373,300 |
EBITDA | 50,600 | 77,800 | 8,900 | -2,000 |
EBIT | 4,500 | 36,700 | -29,400 | -44,900 |
Net Income | -61,800 | 50,500 | 6,300 | -27,200 |
Net Change In Cash | 673,300 | 820,000 | 744,600 | 714,800 |
Cost of Revenue | 12,200 | 11,000 | -96,700 | |
Free Cash Flow | 14,600 | 71,600 | 66,300 | -22,700 |
Cash | 87,700 | 127,700 | 118,500 | 111,500 |
Basic Shares | 46,600 | 47,300 | 48,600 | 47,800 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.36 |
2024-06-30 | $0.29 |
2024-03-31 | $0.19 |
2023-12-31 | $0.32 |
